骨关节炎
化学
滑膜
前列腺素E2
血小板
炎症
药理学
癌症研究
免疫学
内科学
医学
病理
替代医学
作者
Xu-zhao Li,Hongmei Li,Shuai-nan Zhang,Qi Liu,Yumei Wang
标识
DOI:10.1016/j.jchromb.2021.122726
摘要
• Biolabel positions the therapeutic potentials of CMMs in the physiological state. • This pattern effectively explores the therapeutic scopes and advantages of CMMs. • HL produces the dual effects on synovial platelet aggregation through PGE1/PGE2. • HL is suitable for treating synovial diseases, especially osteoarthritis. • The protection of HL on synovium is associated with 4 biochemical processes. Previous research has demonstrated that Herba Lysimachiae (HL) exerts the dual effects on platelet aggregation in the synovium, which may contribute to its protection against synovial lesions under different situations. However, the mechanism is unclear. In the present experiment, a biolabel research based on metabonomics was used to mine the information about the intervention of HL on synovium at the metabolite level, which may help to analyze the regulation of HL on synovial platelet aggregation and its possible treatment in synovial diseases. Synovial metabolic profiling was analyzed using a Shimadzu Nexera UHPLC LC-30A system and an AB SCIEX Triple TOF 4600 mass spectrometer. Enzyme-linked immunosorbent assay (ELISA) was used to verify the biolabels analysis results in the healthy and osteoarthritis rats. Totally, thirteen common metabolites were differentially expressed after treating with HL, and implicated in 2 key pathways (arachidonic acid metabolism and glycerophospholipid metabolism). ELISA showed that HL regulated the expression of prostaglandins E1 and E2 in synovial tissues of the healthy and osteoarthritis rats. This study reveals that HL may regulate synovial platelet aggregation through prostaglandin E1/E2. Additionally, HL is suitable for treating synovial diseases, especially osteoarthritis, which may be associated with platelet aggregation, apoptosis, inflammation, angiogenesis, and carcinogenesis processes.
科研通智能强力驱动
Strongly Powered by AbleSci AI